Table 1
Characteristics of the study groups

Variable Stroke Control Total P value
Total sample (%) 36 (43.4) 47 (56.6) 83 (100)
Sex (female, %) 20 (55.6) 24 (51.1)0.825
Age (yr)0.017*
<65 (%) 6 (16.7) 20 (42.6) 26 (31.3)
≥65 (%) 30 (83.3) 27 (57.4) 57 (68.7)
Hospital day (≥15, %) 18 (50.0) 34 (72.3) 52 (62.7) 0.043*
ASA (≥3, %) 14 (38.9) 1 (2.1) 15 (18.1) 0.021*
Previous constipation (%) 0 0 0
Smoking 10 (27.8) 10 (21.3) 20 (24.1) 0.604
Alcohol 10 (27.8) 8 (17.2) 18 (21.7) 0.288
Underlying disease (%)
Hypertension 27 (75.0) 17 (36.2) 44 (53.0) 0.001*
Diabetes mellitus 15 (41.7) 5 (10.6) 20 (24.1) 0.002*
Atrial fibrillation 11 (30.6) 4 (8.5) 15 (18.1) 0.019*
Past medication (%)
Nitrates 1 (2.8) 2 (4.3) 3 (3.6) 0.999
ACE inhibitor 1 (2.8) 1 (2.1) 2 (2.4) 0.999
Calcium channel blocker 9 (25) 11 (23.4) 20 (24.1) 0.999
Anticonvulsants 1 (2.8) 0 1 (1.2) 0.434
Antidepressants 4 (11.1) 5 (10.6) 9 (10.8) 0.999
Diuretics 1 (2.8) 6 (12.8) 7 (8.4) 0.132
Antihistamine 3 (8.3) 0 3 (3.6) 0.078
Antacid 2 (5.6) 8 (17.2) 10 (12) 0.175
Prokinetics or laxative 0 8 (17.2) 8 (9.6) 0.009*
ASA, American Society of Anesthesiologists physical status classification; ACE, angiotensin-converting enzyme.
*P<0.05.